Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $51.26 and last traded at $51.26, with a volume of 0 shares. The stock had previously closed at $51.26.
Basilea Pharmaceutica Stock Performance
The company has a 50-day moving average of $49.26 and a 200-day moving average of $46.56.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Stories
- Five stocks we like better than Basilea Pharmaceutica
- What Investors Need to Know to Beat the Market
- The Average 401k Balance by Age Explained
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 Stocks to Consider Buying in October
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
